Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults

Cited by (177)

Items 101–177 of 177

1. Association between metabolic syndrome, C-reactive protein, and the risk of primary liver cancer: a large prospective study
   Mengmeng Song, Tong Liu, Hai Liu, Qi Zhang, Qingsong Zhang, Yiming Wang, Xiangming Ma, Liying Cao, Hanping Shi · 2022 · BMC Cancer
2. Serum concentrations of selected adipokines in virus-related liver cirrhosis and hepatocellular carcinoma
   Monika Pazgan−Simon, Jolanta Zuwała−Jagiełło, Michał Kukla, Ewa Grzebyk, Krzysztof Adam Simon · 2020 · Clinical and Experimental Hepatology
3. Statin Use Reduces the Risk of Hepatocellular Carcinoma: An Updated Meta-Analysis and Systematic Review
   Shrouq Khazaaleh, Muhammad Talal Sarmini, Mohammad Alomari, Laith A Al Momani, Bara El Kurdi, Mohammad Maysara Asfari, Zain Almomani, Carlos Romero‐Marrero · 2022 · Cureus
4. Targeting p110gamma in gastrointestinal cancers: attack on multiple fronts
   Marco Falasca, Tania Maffucci · 2014 · Frontiers in Physiology
5. Potassium iodide enhances the anti-hepatocellular carcinoma effect of copper-cysteamine nanoparticle mediated photodynamic therapy on cancer treatment
   X. Zhen, Nil Kanatha Pandey, Eric Horacio Amador, Wen-Pin Hu, Bingqian Liu, Weixia Nong, Wei Chen, Liyi Huang · 2022 · Materials Today Physics
6. Risk of Hepatocellular Carcinoma by Steatotic Liver Disease and Its Newly Proposed Subclassification
   Byeong Geun Song, Aryoung Kim, Myung Ji Goh, Wonseok Kang, Geum‐Youn Gwak, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Dong Hyun Sinn · 2024 · Liver Cancer
7. Metabolic dysfunction-associated steatotic liver disease affects the development of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients
   Shintaro Yamasaki, Takashi Nakahara, Masataka Tsuge, Kenji Yamaoka, Yasutoshi Fujii, Shinsuke Uchikawa, Hatsue Fujino, Atsushi Ono, Eisuke Murakami, Tomokazu Kawaoka et al. · 2025 · Journal of Gastroenterology
8. [Retracted] Distinctive Metabolism‐Associated Gene Clusters That Are Also Prognostic in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma
   Linchao Ding, Shilong Ning, Weijian Hu, Yadong Xue, Shian Yu · 2022 · Oxidative Medicine and Cellular Longevity · Retracted
9. Cholesterol modulates type I/II TGF-β receptor complexes and alters the balance between Smad and Akt signaling in hepatocytes
   Roohi Chaudhary, Laureen S. Goodman, Sai Wang, Anastasia Asimakopoulos, Ralf Weiskirchen, Steven Dooley, Marcelo Ehrlich, Yoav I. Henis · 2024 · Communications Biology
10. Changing Etiological Spectrum of Hepatocellular Carcinoma in India—A Systematic Review and Meta-analysis
    Suprabhat Giri, Ashok Kumar Choudhury, Dibya Lochan Praharaj, Ankita Singh, Arun Vaidya, Sidharth Harindranath, Prajna Anirvan, Shivam Kalia, Akash Shukla · 2024 · Journal of Clinical and Experimental Hepatology
11. Metabolic Profiling Identified a Novel Biomarker Panel for Metabolic Syndrome-Positive Hepatocellular Cancer
    Lin‐Lin Cao, Yi Han, Yuanxiao Wang, Lin Pei, Zhihong Yue, Qin Li, Boyu Liu, Jingwen Cui, Mei Jia, Hui Wang · 2022 · Frontiers in Endocrinology
12. Burden of liver cancer attributable to high fasting plasma glucose: a global analysis based on the global burden of disease study 2019
    Minmin Wang, Jingyi Liu, Yan Liang, Jia Wang, Yinzi Jin, Zhijie Zheng · 2024 · The journal of nutrition health & aging
13. Metabolic Syndrome and Cancer: From Bedside to Bench and Back
    Martine Extermann · 2013 · Interdisciplinary topics in gerontology and geriatrics
14. Global Epidemiology and Risk Factors for Nonalcoholic Fatty Liver Disease
    Abhijit Chowdhury, Zobair M. Younossi · 2015 · Springer eBooks
15. Obesity-associated miR-27a upregulation promotes hepatocellular carcinoma metastasis through suppressing SFRP1
    Yang Chen, Fan Zhang, Yawei Zhao, Kan He, Xiao Zheng, Yue Pan, Dan Shao, Pei Shang, Yongsheng Yang, Dan Zhang et al. · 2018 · OncoTargets and Therapy
16. Overweight in midlife and risk of cancer in late life: A nationwide Swedish twin study
    Cuiping Bao, Rongrong Yang, Nancy L. Pedersen, Weige Xu, Hui Xu, Ruixue Song, Xiuying Qi, Weili Xu · 2018 · International Journal of Cancer
17. Facilitatory effect of insulin treatment on hepatocellular carcinoma development in diabetes
    Hayato Baba, Makoto Kurano, Takeshi Nishida, Hideki Hatta, Ryoji HOKAO, Koichi Tsuneyama · 2017 · BMC Research Notes
18. Effect of 5-aminolevulinic acid on the expression of carcinogenesis-related proteins in cultured primary hepatocytes
    Patricia Regina Menezes, C. B. González, Ana Olı́via de Souza, Durvanei Augusto Maria, Janice Onuki · 2018 · Molecular Biology Reports
19. Association between arterial hypertension and liver outcomes using polygenic risk scores: a population-based study
    Fredrik O. Åberg, Katri Kantojärvi, Ville Männistö, Anna But, Veikko V Salomaa, Teemu Niiranen, Martti A. Färkkilä, Panu K. Luukkonen, Satu Männistö, Annamari Lundqvist et al. · 2022 · Scientific Reports
20. Metabolic syndrome and persistent cervical human papillomavirus infection
    Jieun Lee, Hye Seung Kim, Kyunga Kim, Duk‐Soo Bae, Byoung‐Gie Kim, Chel Hun Choi · 2021 · Gynecologic Oncology
21. Insulin resistance: mechanism and implications for carcinogenesis and hepatocellular carcinoma in NASH
    Luca Montesi, Arianna Mazzotti, Simona Moscatiello, Gabriele Forlani, Giulio Marchesini · 2013 · Hepatology International
22. Diabetes and liver cancer risk: A stronger effect in Whites than Blacks?
    Rebecca Baqiyyah N. Conway, Staci L. Sudenga, Donald A. McClain, William J. Blot · 2020 · Journal of Diabetes and its Complications
23. Relationship between self-reported sleep duration during week-/work-days and metabolic syndrome from NHANES 2013 to 2016
    Xiaojie Feng, Wentao Wu, Fanfan Zhao, Xiang Li, Didi Han, Chengzhuo Li, Fengshuo Xu, Jun Lyu · 2021 · Sleep And Breathing
24. World Cancer Research Fund International Systematic Literature Review
    Teresa Norat, Dagfinn Aune, Deborah Navarro, Leila Abar · 2015
25. Association of a genetic variant in the angiopoietin-like protein 4 gene with metabolic syndrome
    Sara kharazmi-Khorassani, Jasmin Kharazmi Khorassani, Azam Rastgar‐Moghadam, Sara Samadi, Hamideh Ghazizadeh, Maryam Tayefi, Gordon A. Ferns, Majid Ghayour‐Mobarhan, Amir Avan, Habibollah Esmaily · 2019 · BMC Medical Genetics
26. Elevated fasting serum glucose levels increase the risk of hepatocellular carcinoma
    Tong Liu, Wanchao Wang, Haozhe Cui, Miaomiao Sun, Yiming Wang, Xining Liu, Liying Cao, Hai Liu, Siqing Liu · 2019 · Medicine
27. Blood glucose levels and the risk of HPV multiple infections in high-grade squamous intraepithelial lesions: A retrospective cross-sectional study of Chinese patients
    Jie Zhou, Xiang Wei, Hong Yan Xu, Hong Bo Hu, Fan Xiang Li, Wei Zhou, Ye Chen, Zhen Liu · 2022 · Medicine
28. Metabolic serum biomarkers for the prediction of cancer: a follow-up of the studies conducted in the Swedish AMORIS study
    Cecilia Bosco · 2015 · ecancermedicalscience
29. APSA Awardee Submission: Tumor/cancer stem cell marker doublecortin-like kinase 1 in liver diseases
    Charles B. Nguyen, Courtney W. Houchen, Naushad Ali · 2016 · Experimental Biology and Medicine
30. Differential Response of B Cells to an Immunogen, a Mitogen and a Chemical Carcinogen in a Mouse Model System
    Nimisha Saxena, Amar Preet Kaur, Nimai Chand Chandra · 2018 · Europe PMC (PubMed Central)
31. Associations of combined lifestyle and metabolic risks with cancer incidence in the UK biobank study
    Lin Feng, Wen Hu, Chenfenglin Yang, Binglin Cheng, Hongfan Chen, Jiaxin Li, Hanrui Zhu, Haixiang Zhang, Xiang Yuan, Xianyue Ren et al. · 2025 · BMC Cancer
32. Role of cholesterol homeostasis in MASH-driven hepatocellular carcinoma: not just a neutral fat
    Vicent Ribas · 2024 · Exploration of Digestive Diseases
33. Metabolic syndrome and gastrointestinal–hepatobiliary diseases
    Xi‐Hsuan Lin, Jiing–Chyuan Luo · 2016 · Journal of the Chinese Medical Association
34. The Importance of Metabolic Syndrome Status for the Risk of Non-Viral Hepatocellular Carcinoma: A Nationwide Population-Based Study
    Yuri Cho, Eun Ju Cho, Jeong‐Ju Yoo, Young Woon Chang, Goh Eun Chung, In Young Choi, Sang Hyun Park, Kyungdo Han, Yoon Jun Kim, Jung‐Hwan Yoon et al. · 2022 · Frontiers in Oncology
35. Obesity and Gastrointestinal Cancers: Epidemiology
    Nora L. Nock · 2012 · Springer eBooks
36. Obesity and Hepatocellular Carcinoma
    Weiqi Xu, Jun Qing Yu · 2017 · Elsevier eBooks
37. Pooled Analysis of the Associations between Body Mass Index, Total Cholesterol, and Liver Cancer-related Mortality in Japan
    Shigekazu Ukawa, Akiko Tamakoshi, Yoshitaka Murakami, Yutaka Kiyohara, Michiko Yamada, Masato Nagai, Atsushi Satoh, Katsuyuki Miura, Hirotsugu Ueshima, Tomonori Okamura et al. · 2018 · Europe PMC (PubMed Central)
38. Bile acids mediate fructose-associated liver tumour growth in mice
    Stefan R. Hargett, Sujoy Lahiri, Greg M. Kowalski, Susan Corley, Marin E. Nelson, Carolin Lackner, Ellen M. Olzomer, Isabella Aleksovska, Brandon A. Hearn, Riya Shrestha et al. · 2024 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
39. Trans-2-nonadecyl-4-(hydroxymethyl)-1,3-dioxolane (TNHD) purified from freshwater clams markedly alleviates dimethylnitrosamine-induced hepatic fibrosis
    Ya-Ru Kuo, Chen-Yu Tsai, Weisheng Lin, Chi‐I Chang, Ching‐Shu Lai, Min‐Hsiung Pan · 2024 · Journal of Food and Drug Analysis
40. Phase Angle/C-reactive Protein-Index as a Novel Combined Tool for Predicting Liver-Related Hospitalizations in MASLD-Decompensated Cirrhosis
    Marcello Dallio, Mario Romeo, Annachiara Coppola, Giuseppina Martinelli, Claudio Basile, Fiammetta Di Nardo, Carmine Napolitano, Paolo Vaia, Alessia De Gregorio, Alessia Silvestrin et al. · 2025 · Archives of Medical Research
41. Obesity and cancers of the liver, gallbladder, and pancreas
    Matthew J. Sarna, Marcoandrea Giorgi · 2022 · Elsevier eBooks
42. Pathogenetic features of the hepatobiliary system damage in patients with metabolic syndrome
    Olga V. Gaus, В. А. Ахмедов · 2014 · Kazan medical journal
43. Associations of serum uric acid and gamma-glutamyltransferase with cancer in the Vorarlberg Health Monitoring and Promotion Programme (VHM&PP) – a short review
    Michael Edlinger, Gabriele Nagel, Wolfgang Hilbe, Gabriel Diem, Hans Concin, Alexander M. Strasak, Hanno Ulmer · 2011 · memo - Magazine of European Medical Oncology
44. Metabolic Risk Factors in Hepatocellular Carcinoma
    Andra‐Iulia Suceveanu, Laura Mazilu, Andreea Daniela Gheorghe, Anca Pantea Stoian, Felix Voinea, Adrian‐Paul Suceveanu · 2018 · IntechOpen eBooks
45. Survival benefit of metformin use according to cancer diagnosis in diabetic patients with metabolic syndrome
    Ji Soo Park, Soo Jin Moon, Hyung Seok Park, Sang-Hoon Cho · 2024 · Preventive Medicine Reports
46. Residual Risk of Hepatocellular Carcinoma After HCV Eradication: more than meets the eye
    Fabio Salvatore Macaluso, Vincenza Calvaruso, Antonio Craxı̀ · 2015 · Future Microbiology
47. Da NAFLD a MASLD: pillole per endocrinologi
    Vincenza Di Stasi, Elisa Maseroli, Giovanni De Pergola, Linda Vignozzi · 2025 · L Endocrinologo
48. Reducing complications of metabolic dysfunction–associated steatotic liver disease
    Naohiro Wada, Michihiro Iwaki, Takashi Kobayashi, Atsushi Nakajima, Masato Yoneda · 2025 · Expert Review of Gastroenterology & Hepatology
49. Impact of cardiometabolic criteria on the pathogenesis of MASLD and diagnostic performance of non-invasive tests
    Kazuhito Kawata, Hirokazu Takahashi, Taeang Arai, Yuya Seko, Takeshi Chida, Hidenao Noritake, Hidenori Toyoda, Hideki Hayashi, Kanji Yamaguchi, Michihiro Iwaki et al. · 2026 · Journal of Gastroenterology
50. Implications of new obesity definitions in the classification and outcomes of patients with MASLD
    Cai Jp, Terry Cheuk‐Fung Yip, H Y Lin, Grace Lai‐Hung Wong, Andrea O. Y. Luk, Emmanuel A. Tsochatzis, Salvatore Petta, Elisabetta Bugianesi, Masato Yoneda, Ming‐Hua Zheng et al. · 2026 · Hepatology
51. The Role of Granzyme B Activity and Concentration, and Serpin B9 Concentration with Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus
    Hussein S. Alshamary, Qasim Sharhan Al-Mayah, Fadhil Abdulla Abdul-Ridha · 2022 · Pakistan Journal of Medical and Health Sciences
52. Risk prediction of hepatobiliary and pancreatic cancers in elderly Chinese: The Dongfeng‐Tongji cohort
    Jingjing Lyu, Xin Guan, Yuhan Zhou, Huan Guo, Shanshan Cheng, Chaolong Wang · 2023 · Journal of Evidence-Based Medicine
53. The multifaceted role of agents counteracting metabolic syndrome: A new hope for gastrointestinal cancer therapy
    Elena Crecca, Gianfranco Di Giuseppe, C Camplone, Virginia Vigiano Benedetti, Ombretta Melaiu, Teresa Mezza, Chiara Cencioni, Francesco Spallotta · 2025 · Pharmacology & Therapeutics
54. Review on " Hepatocellular carcinoma"
    Neha Yadav, Nidhi Gupta, Rakesh Bharatia · 2024 · International Journal of Pharma Professional’s Research (IJPPR)
55. Metabolisches Syndrom steigert Risiko
    Judith Neumaier · 2012 · Im Focus Onkologie
56. Hepatitis C Virus: Pathogenesis and Host Immune Response
    Albert Ndzengue, Lewis Rowland Roberts · 2014 · Springer eBooks
57. Hepatic and Extrahepatic Malignancies in NAFLD
    Fabio Nascimbeni, Vlad Ratziu · 2015 · Springer eBooks
58. Dieta e fatores de riscos metabólicos para doença cardiovascular em adultos e idosos residentes no município de São Paulo: uma análise por modelos de equações estruturais
    Michelle Alessandra de Castro · 2016
59. Non-alcoholic Fatty Liver Disease and Hepatocellular Carcinoma…
    Hyunwoo Oh, Dae Won Jun · 2017 · Journal of Liver Cancer
60. Organelle dysfunction modulates cholesterol biosynthesis pathway
    Leonardo Pereyra · 2019
61. Dietary Patterns among Overweight/Obese Hispanic Women at High Risk for Type 2 Diabetes
    Mayra Arias‐Gastélum · 2018
62. Blood Glucose Level and Risk of Multiple HPV Infections in Chinese Patients of a Pathologically Confirmed HSIL with HPV Effection: A Restrospective Cross-Sectional Study
    jie zhou, Xiang Wei, Hong yan Xu, Hong bo Hu, Zhan zhong, Fan xiang Li, Wei juan Zhou, Ye Chen, Zhen Liu · 2021 · Research Square
63. Regulación del metabolismo por el GDF11 en células derivadas de tumores hepáticos
    Sharik Hernández-Rizo · 2018
64. Involvement of the intestinal microbiome in the tumor process of the gastrointestinal tract
    О. Е. Кузнецов, V. Tsyrkunov · 2022 · Science and Innovations
65. Exploring immunological perturbations between hepatocellular carcinoma risk, inflammation and obesity
    Elsa Vitale, Alessandro Rizzo, Oronzo Brunetti, Giovanni Brandi · 2024 · Expert Review of Gastroenterology & Hepatology
66. Metabolic Dysfunction-associated Steatotic Liver Disease–related Hepatocellular Carcinoma: Current Research Insights
    Ho Soo Chun, Minjong Lee, Tae Hun Kim · 2024 · Journal of Digestive Cancer Research
67. The significance of metabolism-associated steatotic liver disease and its treatment
    Adam Vašura, Evžen Machytka, Marek Bužga, Jitka Macháčková, Jan Král · 2025 · Vnitřní lékařství
68. Impact of high fasting plasma glucose on liver cancer burden in China: a comprehensive analysis of trends from 1990 to 2021
    Zhouwei Zhan, Wei Lin, Xintong Yao, Shuqi Huang, Shuangting Lan, Lina Zheng, Zengqing Guo, Bijuan Chen · 2025 · Frontiers in Nutrition
69. Burden and trends of NASH-related liver cancer associated with high fasting plasma glucose in China and globally from 1990 to 2021: a population-based analysis of the global burden of disease study
    Youjian Yao, Caifa Ji, Chenchen Zhou, Mei Gui · 2025 · BMJ Open
70. Additional file 1 of Association between metabolic syndrome, C-reactive protein, and the risk of primary liver cancer: a large prospective study
    Song, Mengmeng, Tong Liu, Hai Liu, Zhang, Qi, Qingsong Zhang, Wang, Yiming, Xiangming Ma, Liying Cao, Shi, Hanping · 2022 · Figshare
71. Additional file 1 of Prevalence of metabolic syndrome in primary health settings in Qatar: a cross sectional study
    Syed, Mohamed Ahmed, Al Nuaimi, Ahmed Sameer, Latif Zainel, Abdul Jaleel A., Hamda Abdulla A Qotba · 2020 · Figshare
72. Additional file 1 of Metabolic syndrome and its component traits present gender-specific association with liver cancer risk: a prospective cohort study
    Xia, Bin, Jianjun Peng, Enrico, De Toni, Lu, Kuiqing, Eddie C. Cheung, Kuo, Zichong, He, Qiangsheng, Yan Tang, Liu, Anran, Fan, Die et al. · 2021 · Figshare
73. Déprotection et raccourcissement télomériques dans le carcinome hépatocellulaire
    Lalla Manale El Idrissi · 2013 · theses.fr (ABES)
74. Marqueurs diagnostiques et pronostiques de la stéatohépatite métabolique
    Audrey Coilly · 2019
75. Interaction Patterns Among Risk Factors for Liver Cancer in Patients With Type 2 Diabetes in Primary Care: A Retrospective Cohort Study
    Sarah Tsz Yui Yau, Eman Yee Man Leung, Chi Tim Hung, Martin Chi Sang Wong, Ka Chun Chong, Albert Lee, Eng‐Kiong Yeoh · 2026 · Health Science Reports
76. Association between metabolic risk factors and hepatocellular carcinoma: a systematic review and meta-analysis of cohort studies
    Xiaoli Yang, Peng Fu, H L Liu · 2026 · Frontiers in Medicine
77. Association between metabolic syndrome and mortality among breast cancer survivors: a prospective cohort study
    Ting Zhang, Xiaoni Cai, Shaoqing Qian, Jingxuan Huang · 2026 · Frontiers in Endocrinology